AstraZeneca's numbers are good, but trouble in China could drag it down | Nils Pratley

By The Guardian | Nov 12, 2024 at 02:11 PM EST

Despite exceeding profit forecasts and showing strong growth prospects, AstraZeneca's share price has fallen 17% due to executives being detained in China. Uncertainty looms over the impact, with investors wary of the ongoing investigations' outcomes.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.